Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Print options:   Other options:   Bookmark and Share

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical, however some people find that they add depth to the patient information leaflets. You may find the abbreviations record helpful.

Chloasma (Melasma)

Synonyms: Melasma, Mask of pregnancy, Chloasma medicamentosum

Background

Chloasma comes from the Greek chloazein, to be green. It is considered to be something of a misnomer and many dermatologist prefer the term melasma (melas is Greek for black). The pathophysiology is largely unknown but many differences have been noted between chloasma and normal skin. There is, for example, an increase in the level of melanin, large numbers of melanocytes and melanosomes and increased synthesis of tyrosinase.1 One study also found an increased level of solar elastosis (increase in elastin tissue resulting from sun exposure) and propounded that chloasma was a result of a cumulative sun exposure, in a microenvironment of cutaneous photoageing in which inflammatory cells, particularly mast cells, play a key role.2 Another found an increase in oestrogen receptor expression, suggesting a hormonal link.3

Epidemiology

The exact incidence of chloasma is unknown, but it is a common condition.There is a female to male predilection, with a ratio of 9:1.4

Risk factors

These include:

  • Dark skin - it is common in Asians and Hispanics.4
  • Hormonal - chloasma occurs commonly in pregnancy. One study in Iran found a prevalence among 400 pregnant patients of 15.8%.5 It is rare before puberty and is commonest in women during their reproductive years.4 It is linked to use of oral contraceptives.6 One study of patients with chloasma found that the frequency of thyroid disorders was four times greater compared to a control group.7
  • Sun exposure - this is a well established risk factor.6 Chloasma occurs in sun-exposed areas of the skin.4
  • Genetics - 30% of patients report a positive family history and identical twins with chloasma have been reported.4
  • AIDS - one study reported a group of AIDS patients who developed chloasma-like hyperpigmentation of the face.
  • Other pigmented lesions - one study found a higher incidence of chloasma in women who also had lentigines or melanocytic naevi.8
Presentation4

Patients usually complain of gradual onset areas of dark skin. The colour may vary from tan to brown, but may be black or have a bluish tinge. The distribution is usually symmetrical. Three patterns are commonly seen - centrofacial, malar or mandibular.

Differential diagnosis4
Investigations4

Wood's light helps to locate the pigmentation in the dermis or epidermis. In many cases, it is found in both locations.4

Management4
  • Chloasma is a difficult condition to manage, as sunlight is a considerable aggravating factor and it is difficult to prevent exposure even with high factor protection creams.
  • Mild cases may simply require reassurance. Chloasma associated with pregnancy should resolve spontaneously within a few months. A variety of therapies are available but if treatment in primary care is unsuccessful after six months, specialist referral should be considered.
  • Lightening agents seem to be the best treatment. Hydroquinone 4% has been the commonest used9 but its availability is restricted in some parts of the world due to concerns about its long-term effects (mainly exogenous ochronosis, an irregular blue-black staining affecting sun-exposed skin and nails).10 It is however still currently available in the UK. Other lightening agents that have been tried include tretinoic acid, ascorbic acid and azelaic acid either alone or in combination.
  • Tretinoic acid used as monotherapy can be effective but improvement is slow. It is thought to act by inhibiting the function of melanosomes.
  • Triple therapy cream containing hydroquinone, tretinoin and fluocinolone acetonide has been found in one study to be more cost-effective than hydroquinone alone.11
  • Other agents that have been tried include 4-N -butylresorcinol, phenolic-thioether, 4-isopropylcatechol and kojic acid. One study reports that pidobenzone 4% lipogel used twice a day for sixteen weeks is safe and effective.12 Azelaic acid can be as effective as 4% hydroquinone and is more effective than 2%. The mechanism of action is not well understood.
  • Sometimes a peeling agent such as glycolic acid is added.13
  • Laser treatment, intense pulse light therapy and medium-depth chemical peels are also sometimes employed to hasten resolution. Some authorities believe these destructive 'quick fix' therapies to be unpredictable and associated with an increase incidence of adverse events (e.g. epidermal necrosis, postinflammatory hyperpigmentation and hypertrophic scarring).9 Recent developments in technology have resulted in lasers which are more effective and safer; they have been used successfully in patients resistant to other forms of treatment.14,15 Light microscopy studies show a general reduction in melanocyte content in after a certain type of laser treatment (fractional photothermolysis).16 Moreover, the use of intravenous vitamin C to reduce hyperpigmentation after laser treatment has been reported.17
Prognosis

Most cases resolve eventually, but can take a long time to do so. Continued exposure to sunlight tends to hamper treatment and lead to recurrence. Resolution will also take longer in patients with extensive dermal melanin compared to those in whom pigmentation is mainly in the epidermal layer.4


Document references
  1. Victor FC, Gelber J, Rao B; Melasma: a review. J Cutan Med Surg. 2004 Mar-Apr;8(2):97-102. Epub 2004 May 4. [abstract]
  2. Hernandez-Barrera R, Torres-Alvarez B, Castanedo-Cazares JP, et al; Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma. Clin Exp Dermatol. 2008 May;33(3):305-8. [abstract]
  3. Lieberman R, Moy L; Estrogen receptor expression in melasma: results from facial skin of affected patients. J Drugs Dermatol. 2008 May;7(5):463-5. [abstract]
  4. Montemarano A; Melasma. eMedicine, January 2008.
  5. Moin A, Jabery Z, Fallah N; Prevalence and awareness of melasma during pregnancy. Int J Dermatol. 2006 Mar;45(3):285-8. [abstract]
  6. Foldes EG; Pharmaceutical effect of contraceptive pills on the skin. Int J Clin Pharmacol Ther Toxicol. 1988 Jul;26(7):356-9. [abstract]
  7. Lutfi RJ, Fridmanis M, Misiunas AL, et al; Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab. 1985 Jul;61(1):28-31. [abstract]
  8. Adalatkhah H, Sadeghi-bazargani H, Amini-sani N, et al; Melasma and its association with different types of nevi in women: a case-control study. BMC Dermatol. 2008 Aug 5;8:3. [abstract]
  9. Gupta AK, Gover MD, Nouri K, et al; The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006 Dec;55(6):1048-65. Epub 2006 Sep 28. [abstract]
  10. Bleaching Creams; DermNetz NZ 2009
  11. Cestari T, Adjadj L, Hux M, et al; Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma. J Drugs Dermatol. 2007 Feb;6(2):153-60. [abstract]
  12. Zanieri F, Assad GB, Campolmi P, et al; Melasma: successful treatment with pidobenzone 4% (K5lipogel). Dermatol Ther. 2008 Jul;21 Suppl 1:S18-9. [abstract]
  13. Guevara IL, Pandya AG; Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. Int J Dermatol. 2003 Dec;42(12):966-72. [abstract]
  14. Polnikorn N; Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports. J Cosmet Laser Ther. 2008 Sep;10(3):167-73. [abstract]
  15. MedLite® C Series EO Q-switched Aesthetic Medical Lasers; Medlite 2008
  16. Goldberg DJ, Berlin AL, Phelps R; Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med. 2008 Feb;40(2):134-8. [abstract]
  17. Lee GS; Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report. J Cosmet Laser Ther. 2008 Dec;10(4):234-6. [abstract]

Internet and further reading Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
DocID: 1946
Document Version: 21
DocRef: bgp2152
Last Updated: 14 Jan 2009
Review Date: 14 Jan 2011

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.

Let us know what you think

Your experience

If you'd like to tell us your experience on this subject, please click here

Your comments on this document

If you're a health professional and the guidance given here is at variance with your clinical practice, then please let us know (0 comments posted)

If you're a patient (or a patient group representative) and the treatment offered didn't fit with those described here, then please let us know (0 comments posted)

Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Print options:   Other options:   Bookmark and Share
Want to search some more?
Use the Google Search box below to search our site.

Advertisements













Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>